Among patients with unstable angina or myocardial infarction without ST-segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed. (Funded by Eli Lilly and Daiichi Sankyo; TRILOGY ACS ClinicalTrials.gov number, NCT00699998.).

clinicaltrials.gov Identifier: NCT01448642.

Unfortunately, an incorrect figure was provided in the original manuscript. Figure 1 has to be substituted by Fig. 2. A new Fig. 2 is now provided. The correct Figs. 1 and 2 with according captions are given below. After the NYHA functional class analysis using the McNemar test, the p value is missing in the Results section of the Abstract. The correct text is reproduced below. Results All groups showed similar quality-of-life improvements. Low and moderate intensities training programs improved inspiratory muscle strength, peripheral muscle strength, and walking distance. However, only moderate intensity improved expiratory muscle strength and NYHA functional class (p = 0.031) in HF patients. The online version of the original article can be found under

No abstract

In very long term follow-up, more than 75% of patients exhibited sustained results. Prediction of late favorable results is multifactorial and strongly determined by age, previous symptoms and post-procedural mitral valve area.